Indefinite Delivery Contract 36E79725D0030
Award Date
8/13/25
Last Date to Order
8/12/26
Federal Agency
National Acquisition Center
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency, to Pfizer Inc. to provide an uninterrupted supply of Bevacizumab (ZIRABEV) for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through August 12, 2025. The contract value has a ceiling of...
The federal contract IDV is a single-award Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The contract, valued at a ceiling of $26,399,360.75, is for the supply of pegfilgrastim injectables to the VA, Bureau of Prisons, and Indian Health Service. The contract has a base period of one year and four one-year option periods, with an estimated annual...
This federal contract IDV award is for the supply of ranibizumab ophthalmic injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award indefinite delivery contract, valued at $11,392,063.40, was issued by the VA National Acquisition Center to the prime contractor Biogen U.S. Corporation, a for-profit pharmaceutical manufacturer. The contract has a performance period from December 23, 2023, through December 22, 2025, with four...
This federal contract IDV award is a multiple-award Indefinite Delivery Contract between the Centers for Disease Control and Prevention (CDC) and Pfizer Inc., a global pharmaceutical manufacturer. The $117,849,500 contract, with a performance period ending June 30, 2026, is for the delivery of adult vaccines under the CDC's VACCINES program. As the prime contractor, Pfizer will provide a range of pharmaceutical products to multiple federal healthcare agencies, including the Department of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded to Array Biopharma Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The contract has a ceiling value of $3,309,320.00 and a period of performance through June 30, 2024. The contract provides for the delivery of pharmaceuticals, drugs, and hematology-related products to support the healthcare needs of...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Pfizer Inc. as the prime contractor. The contract has a total ceiling value of $83,732,812.80 and a period of performance from September 15, 2020 to September 14, 2025, including a base year and four one-year option periods. The purpose of this IDC is to procure rituximab vials for the Department of Veterans Affairs, Department of Defense, Bureau of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pfizer Inc. as the prime contractor. The single-award IDC has a ceiling value of $74,038,216.80 and a base ordering period from September 15, 2025 to September 14, 2026, with four one-year option periods. The contract is for the procurement of Rituximab and its biosimilar products to support multiple federal healthcare agencies,...
The Department of Veterans Affairs National Acquisition Center has awarded Organon LLC a single-award Indefinite Delivery Contract (IDC) worth up to $119,538,562.32 to provide Infliximab Injection 100 mg/vial, a biosimilar medication, to the VA, Bureau of Prisons, and Indian Health Service. The contract has a 1-year base period starting September 1, 2023 with four 1-year option periods, for a total potential period of performance through August 31, 2026. This IDC supports the VA's Pharmaceutical...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, covers a wide range of pharmaceutical and medical supply products to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes,...